Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Capital Markets

Inovalon Holdings Inc A / Equity Capital Markets

<ul><li>This is a special one-time coverage on Inovalon Holdings, a leading provider of data analytics and cloud-based platforms to the healthcare and insurance industries.</li><li>The company’s platform has the ability to access, aggregate, normalize, and analyze real-time and on-demand patient-specific data from a number of disparate healthcare datasets and disparate connected healthcare systems.</li><li>Inovalon has had a lower capex over the past few quarters and its expected free cash flows make it a strong PE acquisition candidate.</li></ul>

This is a special one-time coverage on Inovalon Holdings, a leading provider of data analytics and cloud-based platforms to the healthcare and insurance industries.The company’s platform has the ability to access, aggregate, normalize, and analyze real-time and on-demand patient-specific data from a number of disparate healthcare datasets and disparate connected healthcare systems.Inovalon has had a lower capex over the past few quarters and its expected free cash flows make it a strong PE acquisition candidate.

Inovalon Holdings Inc. - An M&A Arbitrage Opportunity? Read Our Report Which Includes Key Drivers

United States

Inovalon Holdings, Inc. is a data analytics and technology company. The Company combines cloud-based data analytics and data-driven intervention platforms to improve clinical and quality outcomes, financial performance, and utilization within the healthcare industry.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Inovalon Holdings Inc A (INOV US)

Inovalon Holdings Inc. - An M&A Arbitrage Opportunity? Read Our Report Which Includes Key Drivers

This is a special one-time coverage on Inovalon Holdings, a leading provider of data analytics and cloud-based platforms to the healthcare and...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)